Basit öğe kaydını göster

Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer

dc.contributor.authorYasasever, Vildan
dc.contributor.authorSoydinc, Hilal
dc.contributor.authorYAZAR, Aziz
dc.contributor.authorErtan, Esra
dc.contributor.authorTas, Faruk
dc.contributor.authorUstuner, Zeki
dc.date.accessioned2021-03-05T20:33:27Z
dc.date.available2021-03-05T20:33:27Z
dc.date.issued2011
dc.identifier.citationErtan E., Soydinc H., YAZAR A., Ustuner Z., Tas F., Yasasever V., "Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer", TUMORI, cilt.97, ss.286-289, 2011
dc.identifier.issn0300-8916
dc.identifier.otherav_d4b3c8c5-40ec-447c-b1a7-f35badccdcf8
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/140384
dc.identifier.urihttps://doi.org/10.1700/912.10023
dc.description.abstractAims and background. The aim of the study was to investigate the alteration in serum matrix metalloproteinase-9 (MMP-9) levels after chemotherapy and the association between the changes in serum levels of MMP-9 and response to chemotherapy in patients with advanced stage non-small cell lung cancer.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleMatrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer
dc.typeMakale
dc.relation.journalTUMORI
dc.contributor.departmentEskişehir Osmangazi Üniversitesi , ,
dc.identifier.volume97
dc.identifier.issue3
dc.identifier.startpage286
dc.identifier.endpage289
dc.contributor.firstauthorID7269


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster